Manipulation of the growth hormone IGF-I axis in type one diabetes : insight into physiological mechanisms and potential strategies for therapeutic intervention
Methods: 1) In a crossover study, 2 doses (5 and 10mg) of a specific GH antagonist (B2036-PEG, Somavert) were each administered for 3 weeks to 7 subjects, in random order with a 3 week washout period. Euglycaemic clamp techniques incorporating cold isotopes were used to quantify carbohydrate and fat...
| Main Author: | |
|---|---|
| Published: |
University of Edinburgh
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.663836 |